Literature DB >> 9126443

Infectious diseases and immunity: special reference to major histocompatibility complex.

N Singh1, S Agrawal, A K Rastogi.   

Abstract

Human leukocyte antigens (HLAs) are an inherent system of alloantigens, which are the products of genes of the major histocompatibility complex (MHC). These genes span a region of approximately 4 centimorgans on the short arm of human chromosome 6 at band p 21.3 and encode the HLA class I and class II antigens, which play a central role in cell-to-cell interaction in the immune system. These antigens interact with the antigen-specific cell surface receptors of T lymphocytes (TCR) thus causing activation of the lymphocytes and the resulting immune response. Class I antigens restrict cytotoxic T-cell (CD8+) function thus killing viral infected targets, while class II antigens are involved in presentation of exogenous antigens to T-helper cells (CD4+) by antigen presenting cells (APC). The APC processes the antigens, and the immunogenic peptide is then presented at the cell surface along with the MHC molecule for recognition by the TCR. Since the MHC molecules play a central role in regulating the immune response, they may have an important role in controlling resistance and susceptibility to diseases. In this review we have highlighted studies conducted to look for an association between HLA and infectious diseases; such studies have had a variable degree of success because the pathogenesis of different diseases varies widely, and most diseases have a polygenic etiology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126443      PMCID: PMC2627588          DOI: 10.3201/eid0301.970105

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  47 in total

1.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

2.  Study of the association of HLA class I antigens with kala-azar.

Authors:  Z Faghiri; S Z Tabei; F Taheri
Journal:  Hum Hered       Date:  1995 Sep-Oct       Impact factor: 0.444

3.  Tuberculoid leprosy in Mexicans is associated with HLA-DR3.

Authors:  C Gorodezky; J Flores; N Arevalo; L E Castro; A Silva; O Rodriguez
Journal:  Lepr Rev       Date:  1987-12       Impact factor: 0.537

4.  Strain difference of delayed-type hypersensitivity to BCG and its genetic control in mice.

Authors:  R M Nakamura; T Tokunaga
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

5.  From hepatitis to hepatoma: lessons from type B viral hepatitis.

Authors:  D S Chen
Journal:  Science       Date:  1993-10-15       Impact factor: 47.728

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  HLA-DR-associated genetic control of the type of leprosy in a population from surinam.

Authors:  W van Eden; R R de Vries; J D'Amaro; I Schreuder; D L Leiker; J J van Rood
Journal:  Hum Immunol       Date:  1982-07       Impact factor: 2.850

8.  Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle.

Authors:  L R Bisset
Journal:  Med Hypotheses       Date:  1994-12       Impact factor: 1.538

9.  Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation.

Authors:  Z Yao; E Maraskovsky; M K Spriggs; J I Cohen; R J Armitage; M R Alderson
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

10.  Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method.

Authors:  R Winchester; Y Chen; S Rose; J Selby; W Borkowsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  7 in total

Review 1.  Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response.

Authors:  G A Poland
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 2.  Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections.

Authors:  Sadeep Medhasi; Narisara Chantratita
Journal:  J Immunol Res       Date:  2022-05-26       Impact factor: 4.493

3.  Prevalent HLA Class II Alleles in Mexico City Appear to Confer Resistance to the Development of Amebic Liver Abscess.

Authors:  Eric G Hernández; Julio Granados; Oswaldo Partida-Rodríguez; Olivia Valenzuela; Edgar Rascón; Ulises Magaña; Mónica Escamilla-Tilch; Alberto López-Reyes; Miriam Nieves-Ramírez; Enrique González; Patricia Morán; Liliana Rojas; Alicia Valadez; Alexandra Luna; Francisco J Estrada; Carmen Maldonado; Cecilia Ximénez
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

4.  Role of genetic heterogeneity in determining the epidemiological severity of H1N1 influenza.

Authors:  Narmada Sambaturu; Sumanta Mukherjee; Martín López-García; Carmen Molina-París; Gautam I Menon; Nagasuma Chandra
Journal:  PLoS Comput Biol       Date:  2018-03-21       Impact factor: 4.475

5.  A community-based prospective cohort study of dengue viral infection in Malaysia: the study protocol.

Authors:  Nowrozy Kamar Jahan; Mohtar Pungut Ahmad; Amreeta Dhanoa; Cheong Yuet Meng; Lau Wee Ming; Daniel D Reidpath; Pascale Allotey; Anuar Zaini; Maude Elvira Phipps; Quek Kia Fatt; Aman Bin Rabu; Rowther Sirajudeen; Ahmad AbdulBasitz Ahmad Fatan; Faidzal Adlee Ghafar; Hamdan Bin Ahmad; Iekhsan Othman; Sharifah SyedHassan
Journal:  Infect Dis Poverty       Date:  2016-08-11       Impact factor: 4.520

6.  A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.

Authors:  Kay Poulton; Paul Wright; Pamela Hughes; Sinisa Savic; Matthew Welberry Smith; Malcolm Guiver; Muir Morton; David van Dellen; Eleni Tholouli; Robert Wynn; Brendan Clark
Journal:  Int J Immunogenet       Date:  2020-07-05       Impact factor: 2.385

7.  Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association.

Authors:  Jorge Seixas; Jorge Atouguia; Teófilo Josenando; Gedeão Vatunga; Constantin Miaka Mia Bilenge; Pascal Lutumba; Christian Burri
Journal:  Trop Med Infect Dis       Date:  2020-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.